Zhejiang Ausun Pharmaceutical Co Ltd (603229) — Capital Reinvestment Ratio
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥121.49 Million) in capital expenditures (CN¥27.68 Million). See how much free cash does Zhejiang Ausun Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Ausun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhejiang Ausun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Ausun Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Ausun Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Zhejiang Ausun Pharmaceutical Co Ltd (603229) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | CN¥156.51 Million | CN¥104.45 Million | ▲ +6.7% |
| 2024 | 0.63x | CN¥177.93 Million | CN¥111.30 Million | ▼ -15.1% |
| 2023 | 0.74x | CN¥221.85 Million | CN¥163.47 Million | ▼ -67.3% |
| 2022 | 2.26x | CN¥120.57 Million | CN¥271.91 Million | ▲ +26.2% |
| 2021 | 1.79x | CN¥173.90 Million | CN¥310.85 Million | ▲ +166.3% |
| 2020 | 0.67x | CN¥138.47 Million | CN¥92.95 Million | ▲ +18.7% |
| 2019 | 0.57x | CN¥87.73 Million | CN¥49.63 Million | ▼ -88.2% |
| 2018 | 4.79x | CN¥11.50 Million | CN¥55.05 Million | ▲ +311.9% |
| 2017 | 1.16x | CN¥46.78 Million | CN¥54.36 Million | ▲ +153.1% |
| 2016 | 0.46x | CN¥93.21 Million | CN¥42.79 Million | ▼ -42.5% |
| 2015 | 0.80x | CN¥53.63 Million | CN¥42.80 Million | ▼ -25.8% |
| 2014 | 1.08x | CN¥21.45 Million | CN¥23.08 Million | ▼ -53.9% |
| 2013 | 2.33x | CN¥15.73 Million | CN¥36.71 Million | — |